Dipyridamole

Dipyridamole

SCHEMBL17044166

CO.OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PDE10APDE1APDE1BPDE1CPDE2APDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE6APDE6BPDE6CPDE6DPDE6GPDE6HPDE7APDE7BPDE8APDE8BPDE9ASLC29A1

The experimentally established mechanism targets of Dipyridamole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 known ✓ Q99808 19/20 0.94
PDE2A known ✓ O00408 1/20 0.94
PDE6D known ✓ O43924 1/20 0.94
PDE8A known ✓ O60658 1/20 0.94
PDE5A known ✓ O76074 1/20 0.94
PDE6A known ✓ P16499 1/20 0.94
PDE6G known ✓ P18545 1/20 0.94
PDE4A known ✓ P27815 1/20 0.94
PDE6B known ✓ P35913 1/20 0.94
PDE6C known ✓ P51160 1/20 0.94
PDE1A known ✓ P54750 1/20 0.94
PDE1B known ✓ Q01064 1/20 0.94
PDE4B known ✓ Q07343 1/20 0.94
PDE4C known ✓ Q08493 1/20 0.94
PDE4D known ✓ Q08499 1/20 0.94
PDE3B known ✓ Q13370 1/20 0.94
PDE7A known ✓ Q13946 1/20 0.94
PDE6H known ✓ Q13956 1/20 0.94
PDE1C known ✓ Q14123 1/20 0.94
PDE3A known ✓ Q14432 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dipyridamole SCHEMBL16119 0.97 SLC29A1 (1.00) SLC29A1ADORA3KDM4EMEN1PDE2A
Dipyridamole SCHEMBL3980595 0.97 SLC29A1 (1.00) SLC29A1ADORA3KDM4EMEN1PDE2A
SCHEMBL30416820 0.97 SLC29A1 (1.00) SLC29A1ADORA3KDM4EMEN1PDE2A
Dipyridamole SCHEMBL29381078 0.97 SLC29A1 (1.00) SLC29A1ADORA3KDM4EMEN1PDE2A
Dipyridamole SCHEMBL611283 0.95 SLC29A1 (0.91) SLC29A1ADORA3KDM4EMEN1PDE2A
Dipyridamole SCHEMBL7362290 0.95 SLC29A1 (0.97) SLC29A1ADORA3KDM4EMEN1PDE2A
Dipyridamole SCHEMBL29002462 0.95 SLC29A1 (0.97) SLC29A1ADORA3KDM4EMEN1PDE2A
Dipyridamole SCHEMBL9743915 0.95 SLC29A1 (0.97) SLC29A1ADORA3KDM4EMEN1PDE2A
Dipyridamole SCHEMBL7998210 0.95 SLC29A1 (0.97) SLC29A1ADORA3KDM4EMEN1PDE2A
Dipyridamole SCHEMBL28672572 0.95 SLC29A1 (0.97) SLC29A1ADORA3KDM4EMEN1PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100480697-C Quality control method for injection containing breviscapini and dipyridamole GUIYANG YUNYAN XICHUANG PHARM (CN) 2009-04-22 CN claimed
WO-2023079290-A1 DRUG COATED BALLOON ARTERIUS LIMITED (GB) 2023-05-11 WO disclosed
EP-2296685-B1 AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS SYNERGY PHARMACEUTICALS INC (US) 2015-09-02 EP disclosed
CN-100480697-C Quality control method for injection containing breviscapini and dipyridamole GUIYANG YUNYAN XICHUANG PHARM (CN) 2009-04-22 CN disclosed
CN-1808114-A Quality control method for injection containing breviscapini and dipyridamole GUIYANG YUNYAN XICHUANG PHARM (CN) 2006-07-26 CN disclosed